More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
KannaLife™ Sciences part of CNN’s Documentary –  Weed 3: The Marijuana Revolution

KannaLife™ Sciences part of CNN’s Documentary – Weed 3: The Marijuana Revolution

by adminAdrianRamirez | Apr 20, 2015 | Company News, Kannalife Sciences, Media Coverage

by Stuart Titus, CEO On behalf of Medical Marijuana Inc. (OTC: MJNA), I’m very excited that our portfolio company, KannaLife™ Sciences, Inc. is part of the CNN special Weed 3: The Marijuana Revolution with Dr. Sanjay Gupta. Having been a Board Member of KannaLife™ for...

Photo Release — Medical Marijuana Inc.’s MPSI Featured by CNN Money, Secures “420” Denver Events

by adminAdrianRamirez | Apr 16, 2015 | Company News, Industry Updates, MPS International, Press Releases

SAN DIEGO, April 16, 2015 (GLOBE NEWSWIRE) — No stranger to providing security for the quickly growing cannabis industry, Medical Marijuana, Inc.’s (OTC Pink:MJNA) subsidiary, Wellness Managed Services’ MPS International (MPSI), has secured exclusive...
Medical Marijuana, Inc. Announces Appointment of New President, CEO and Additional Members to the Board of Directors

Medical Marijuana, Inc. Announces Appointment of New President, CEO and Additional Members to the Board of Directors

by adminAdrianRamirez | Mar 18, 2015 | Company News, Press Releases

Longtime Cannabis Industry Veteran and Wall Street Finance Expert ‘Humbled’ to Take the Helm of the First-Ever Publicly-Traded Cannabis Company SAN DIEGO, March 18, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial...
Medical Marijuana Inc. Announces New CEO and Members of the Board of Directors

Medical Marijuana Inc. Announces New CEO and Members of the Board of Directors

by adminAdrianRamirez | Mar 18, 2015 | Company News, Press Releases

Longtime Cannabis Industry Veteran and Wall Street Finance Expert ‘Humbled’ to Take the Helm of the First-Ever Publicly-Traded Cannabis Company SAN DIEGO, March 18, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial...
Kannalife Sciences, Inc. Adds Dr. Bennet Omalu to its Scientific Advisory Board

Kannalife Sciences, Inc. Adds Dr. Bennet Omalu to its Scientific Advisory Board

by adminAdrianRamirez | Mar 4, 2015 | Company News, Kannalife Sciences, Press Releases

Huntington, NY – Kannalife Sciences, Inc. (“Kannalife”) announces that Dr. Bennet Omalu, MD has joined its Scientific Advisory Board to assist the Company in the advancement of its research and development efforts towards the use of cannabinoid therapeutics for the...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.